Search results
Izokibep shows promise in psoriatic arthritis trial By Investing.com
Investing.com· 1 day agoACELYRIN, INC. (NASDAQ: SLRN), a biopharmaceutical company specializing in immunology, announced...
Rhode Islanders face massive barriers to health care | Opinion
Gannett via AOL· 9 hours agoPaul Adam, of Woonsocket, is the Rhode Island Lead Volunteer for the American Cancer Society Action Network. Psoriatic arthritis controlled my life, taking ...
AbbVie’s RINVOQ now indicated for paediatric arthritis in US
Pharmaceutical Technology via Yahoo Finance· 2 days agoAbbVie has announced that its RINVOQ (upadacitinib) is now indicated for treating polyarticular...
FDA Extends Upadacitinib Indications to Kids With Arthritis
Medscape· 3 days agoThe JAK inhibitor's safety profile for patients as young as 2 years was similar to known to the...
Simponi and Simponi Aria cost: Reducing long-term costs and more
Medical News Today· 4 days agoSimponi and Simponi Aria both contain the active ingredient golimumab. A biosimilar medication is a...
My patients can’t afford two crucial medications, and Big Pharma should be held accountable
Colorado Newsline via Yahoo News· 17 hours agoAs a physician, I am encouraged and impressed with the work that Colorado’s Prescription Drug...
India Has Low-Cost CAR T-Cell Therapy: Can US Follow Suit?
Medscape· 22 hours agoDr Maurie Markman discusses a news report on decreasing the cost of CAR-T therapy and the potential...
AbbVie (ABBV) Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU
Zacks via Yahoo Finance· 4 days agoAbbVie (ABBV) announces that the EMA's CHMP issued a positive opinion on its regulatory filing...
Star Singer's Illness; AI Imitating the Dead; Internet-Addicted Brains
MedPage Today· 2 days agoHalsey said she has been battling an undisclosed illness and is "lucky to be alive"; the singer said...
VENTYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Ventyx Biosciences, Inc. on Behalf of...
Morningstar· 3 days agoBragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Ventyx Biosciences, Inc. (NASDAQ: VTYX) on behalf of long-term stockholders ...